Using Both TAS-102 and Regorafenib in Metastatic CRC Patients

Howard S. Hochster, MD of Yale Cancer Center discusses how to use both TAS-102 and Regorafenib in patients with metastatic colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO GI) in... Author: obr Added: 01/24/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts